Bayer aborts late-stage trial of anticoagulant drug due to inefficacy
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..